Agilent Technologies, Inc.
Revenue Breakdown
| Fiscal Year | Life Sciences and Diagnostics Markets | Agilent CrossLab | Applied Markets |
|---|---|---|---|
| FY2023 | $2.78B | $2.66B | $1.40B |
| FY2024 | $2.47B | $2.75B | $1.30B |
| FY2025 | $2.73B | $2.91B | $1.31B |
Revenue Breakdown
| Fiscal Year | Life Sciences and Diagnostics Markets | Agilent CrossLab | Applied Markets |
|---|---|---|---|
| FY2023 | $2.78B | $2.66B | $1.40B |
| FY2024 | $2.47B | $2.75B | $1.30B |
| FY2025 | $2.73B | $2.91B | $1.31B |